Related references
Note: Only part of the references are listed.Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Yellow Oil in Healthy Participants
Erica N. Peters et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2022)
A placebo-controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans
Caroline A. Arout et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Mortality in patients with behavioural and psychological symptoms of dementia: a registry-based study
Vanja Bransvik et al.
AGING & MENTAL HEALTH (2021)
Cannabinoid treatment for autism: a proof-of-concept randomized trial
Adi Aran et al.
MOLECULAR AUTISM (2021)
Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder
Shani Poleg et al.
TRANSLATIONAL PSYCHIATRY (2021)
Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn's Disease, a Randomised Controlled Trial
Timna Naftali et al.
JOURNAL OF CROHNS & COLITIS (2021)
Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia
Viktoria Muehlbauer et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
Cannabinoids for the treatment of dementia
Dina Bosnjak Kuharic et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials
George T. Grossberg et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2020)
Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates
Monika Marcinkowska et al.
CNS DRUGS (2020)
Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease
Stephanie Martins de Faria et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature
Shannon Inglet et al.
ANNALS OF PHARMACOTHERAPY (2020)
Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia: a systematic review and network meta-analysis
Jennifer A. Watt et al.
BMC GERIATRICS (2020)
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
Maria S. Garcia-Gutierrez et al.
BIOMOLECULES (2020)
Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis
Myrlene Sanon Aigbogun et al.
BMC NEUROLOGY (2019)
Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
Nathan Herrmann et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
Lihi Bar-Lev Schleider et al.
SCIENTIFIC REPORTS (2019)
Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study
Adi Aran et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2019)
Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review
Jodie Belinda Hillen et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2019)
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
Philip McGuire et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer
Lihi Bar-Lev Schleider et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly
Ran Abuhasira et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders
Stephanie Libzon et al.
JOURNAL OF CHILD NEUROLOGY (2018)
No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Ila M. P. Linares et al.
FRONTIERS IN PHARMACOLOGY (2018)
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Eric P. Baron
HEADACHE (2018)
Causes of nursing home placement for older people with dementia: a systematic review and meta-analysis
Sandeep Toot et al.
INTERNATIONAL PSYCHOGERIATRICS (2017)
Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes
Ryan Vandrey et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2017)
Endocannabinoid system in neurodegenerative disorders
Balapal S. Basavarajappa et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cannabidiol: State of the art and new challenges for therapeutic applications
Simona Pisanti et al.
PHARMACOLOGY & THERAPEUTICS (2017)
The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia
Victor I. Reus et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
CBD-enriched medical cannabis for intractable pediatric epilepsy The current Israeli experience
Michal Tzadok et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2016)
Management of the behavioral and psychological symptoms of dementia
Elizabeth Hersch
Clinical Interventions in Aging (2016)
Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial
Geke A. H. van den Elsen et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2015)
Neuropsychiatric Symptoms as Predictors of Progression to Severe Alzheimer's Dementia and Death: The Cache County Dementia Progression Study
Matthew E. Peters et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial
Paul B. Rosenberg et al.
INTERNATIONAL PSYCHOGERIATRICS (2015)
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia A randomized controlled trial
Geke A. H. van den Elsen et al.
NEUROLOGY (2015)
Molecular Targets of Cannabidiol in Neurological Disorders
Clementino Ibeas Bih et al.
NEUROTHERAPEUTICS (2015)
Dronabinol for the Treatment of Agitation and Aggressive Behavior in Acutely Hospitalized Severely Demented Patients with Noncognitive Behavioral Symptoms
Matthew R. Woodward et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2014)
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Orrin Devinsky et al.
EPILEPSIA (2014)
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment
M. Serpell et al.
EUROPEAN JOURNAL OF PAIN (2014)
Effects of cannabidiol in the treatment of patients with Parkinson's disease: An exploratory double-blind trial
Marcos Hortes N. Chagas et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
Javier Fernandez-Ruiz et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Cannabidiol enhances consolidation of explicit fear extinction in humans
Ravi K. Das et al.
PSYCHOPHARMACOLOGY (2013)
Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers
David A. Gorelick et al.
AMERICAN JOURNAL ON ADDICTIONS (2013)
Risk of Mortality Among Individual Antipsychotics in Patients With Dementia
Helen C. Kales et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
Ana Maria Martin-Moreno et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Behavioral and Psychological Symptoms of Dementia
J. Cerejeira et al.
Frontiers in Neurology (2012)
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Ethan B. Russo
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Assessing neuropsychiatric symptoms in nursing home patients with dementia: reliability and Reliable Change Index of the Neuropsychiatric Inventory and the Cohen-Mansfield Agitation Inventory
Sytse U. Zuidema et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)
Randomized, Controlled Crossover Trial of Dronabinol, 2.5 mg, for Agitation in 2 Patients With Dementia
Sebastian Walther et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
Jose Alexandre S. Crippa et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naive Social Phobia Patients
Mateus M. Bergamaschi et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Clinical features and multidisciplinary approaches to dementia care
Jacob H. G. Grand et al.
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE (2011)
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
Mark A. Ware et al.
ANESTHESIA AND ANALGESIA (2010)
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Mark A. Ware et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol A Neural Basis for the Effects of Cannabis sativa on Learning and Psychosis
Sagnik Bhattacharyya et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Disruptive Behavior as a predictor in Alzheimer disease
Nikolaos Scarmeas et al.
ARCHIVES OF NEUROLOGY (2007)
The geriatric depression scale and the Cornell Scale for Depression in Dementia. A validity study
Alex Korner et al.
NORDIC JOURNAL OF PSYCHIATRY (2006)
Risk of nursing home admission in association with mental illness nationally in the department of veterans affairs
EA Miller et al.
MEDICAL CARE (2006)
Quality of life in dementia: more than just cognition. An analysis of associations with quality of life in dementia
S Banerjee et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
The use of unequal randomisation ratios in clinical trials: A review
JC Dumville et al.
CONTEMPORARY CLINICAL TRIALS (2006)
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
DR Blake et al.
RHEUMATOLOGY (2006)
Factor analysis of the Cohen-Mansfield Agitation Inventory in three large samples of nursing home patients with dementia and behavioral disturbance
J Rabinowitz et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2005)
Risk of death with atypical antipsychotic drug treatment for dementia - Meta-analysis of randomized placebo-controlled trials
LS Schneider et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Delusions and hallucinations are associated with worse outcome in Alzheimer disease
N Scarmeas et al.
ARCHIVES OF NEUROLOGY (2005)
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
DJ Rog et al.
NEUROLOGY (2005)
Pharmacological treatment of neuropsychiatric symptoms of dementia - A review of the evidence
KM Sink et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial
JS Berman et al.
PAIN (2004)
Pharmacokinetics and pharmacodynamics of cannabinoids
F Grotenhermen
CLINICAL PHARMACOKINETICS (2003)
Measuring change in psychiatric symptoms using the Neuropsychiatric Inventory: Nursing Home version
GL Iverson et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2002)
The use of the neuropsychiatric inventory in nursing home residents -: Characterization and measurement
S Wood et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2000)
Treatment of agitation in AD - A randomized, placebo-controlled clinical trial
L Teri et al.
NEUROLOGY (2000)
Predicting elderly people's risk for nursing home placement, hospitalization, functional impairment, and mortality: A synthesis
EA Miller et al.
MEDICAL CARE RESEARCH AND REVIEW (2000)
Share Paper
